Nutritional Products was Abbott Laboratories’s largest segment in fiscal 2016, bringing in $6.90B of $20.85B (33%).
| Statement Business Segments | FY 2009 | FY 2010 | FY 2011 | FY 2013 | FY 2014 | FY 2015 | FY 2016 |
|---|---|---|---|---|---|---|---|
| Revenue, Net | — | — | — | — | |||
| Nutritional Products | $6.74B | $6.95B | $6.98B | $6.90B | |||
| Salesrevenuenet | — | — | — | — | |||
| Diagnostic Products | $4.55B | $4.72B | $4.65B | $4.81B | |||
| Established Pharmaceutical Products | $2.86B | $3.12B | $3.72B | $3.86B | |||
| Vascular Products | $3.01B | $2.99B | — | — | |||
| Cardiovascular & Neuromodulation Products | — | — | $2.79B | $2.90B | |||
| Other | $2.50B | $2.47B | $2.27B | $2.39B | |||
| Total | $19.66B | $20.25B | $20.41B | $20.85B |
Abbott Laboratories brought in $20.85B from its five segments in fiscal 2016, the year ended December 31, 2016. That was up 2.2% from $20.41B in fiscal 2015. Nutritional Products was the largest at $6.90B (33.1%), ahead of Diagnostic Products at $4.81B (23.1%) and Established Pharmaceutical Products at $3.86B (18.5%). The other two segments brought in $5.28B combined.
Compared with fiscal 2015, Other grew fastest, up 5.0% to $2.39B, while Nutritional Products fell the most, down 1.1% to $6.90B.
Abbott Laboratories began breaking out Cardiovascular & Neuromodulation Products in fiscal 2015, when it brought in $2.79B. Abbott Laboratories stopped reporting Vascular Products as a separate segment after fiscal 2014, when it brought in $2.99B.
United States was Abbott Laboratories’s largest region in fiscal 2017, bringing in $9.67B of $27.39B (35%).
| Geography | FY 2010 | FY 2011 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|
| United States | $6.12B | $6.27B | $6.49B | $9.67B | |||
| Salesrevenuenet | — | — | — | — | |||
| Revenue, Net | — | — | — | — | |||
| All Other Countries | $5.32B | $4.55B | $7.96B | $5.74B | |||
| China | $1.32B | $1.80B | $1.73B | $2.15B | |||
| Germany | $978.00M | $1.00B | $1.04B | $1.37B | |||
| Japan | $968.00M | $895.00M | $924.00M | $1.26B | |||
| The Netherlands | $788.00M | $855.00M | $830.00M | $929.00M | |||
| India | $1.01B | $1.05B | $1.11B | $1.24B | |||
| United Kingdom | $447.00M | $430.00M | $377.00M | $498.00M | |||
| Switzerland | $707.00M | $784.00M | $766.00M | $841.00M | |||
| France | — | $375.00M | $352.00M | $628.00M | |||
| Italy | $436.00M | $383.00M | $365.00M | $507.00M | |||
| Canada | $462.00M | $428.00M | $408.00M | $443.00M | |||
| Russia | $536.00M | $483.00M | $554.00M | $664.00M | |||
| Brazil | $508.00M | $381.00M | $410.00M | $541.00M | |||
| Vietnam | $357.00M | $331.00M | $434.00M | $427.00M | |||
| Colombia | $283.00M | $388.00M | $424.00M | $494.00M | |||
| Total | $20.25B | $20.41B | $24.18B | $27.39B |
Abbott Laboratories brought in $27.39B from its 16 regions in fiscal 2017, the year ended December 31, 2017. That was up 13.3% from $24.18B in fiscal 2016. United States was the largest at $9.67B (35.3%), ahead of All Other Countries at $5.74B (21.0%) and China at $2.15B (7.8%). The other 13 regions brought in $9.83B combined.
Compared with fiscal 2016, France grew fastest, up 78.4% to $628.00M, while All Other Countries fell the most, down 27.9% to $5.74B.
Abbott Laboratories (ABT) reports its revenue by statement business segments and by geography. In fiscal 2016, Nutritional Products was its largest segment, bringing in $6.90B (33.1% of the total), followed by Diagnostic Products at $4.81B (23.1%).
Nutritional Products was Abbott Laboratories' largest segment in fiscal 2016, bringing in $6.90B, or 33.1% of the $20.85B total across its five segments.
United States was Abbott Laboratories' largest region in fiscal 2017, bringing in $9.67B, or 35.3% of the $27.39B total across its 16 regions.
Among Abbott Laboratories' segments that make up at least 2% of revenue, Other grew fastest in fiscal 2016, up 5.0% from $2.27B to $2.39B.
Every figure comes from Abbott Laboratories' annual financial filings, as reported. Each line keeps the name Abbott Laboratories gives it, and years follow its fiscal calendar.
Abbott Laboratories' revenue by statement business segments goes back to fiscal 2009, with figures through fiscal 2016. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.